MINIMALLY INVASIVE GLAUCOMA SURGERY (MIGS): COMPARISON OF TRABECULAR VERSUS SUPRACHOROIDAL ROUTE
Abstract
Introduction: Because of the high rate of complications associated with traditional glaucoma filtering surgery, various research were launched to develop a new device, such as drainage channels, such as Glaucoma Drainage Devices.
Objective: To compare the efficacy and safety of trabecular route and suprachoroidal MIGS in eyes with mild to moderate glaucoma with and without cataract extraction of these two devices.
Methods: Literature search was conducted using online database such as Google Scholar, Pubmed, Survey of Ophtalmology, and Clinical Key.
Result: Since the IOP-lowering efficacy of these treatments is restricted by episcleral venous pressure, MIGS targeting the trabecular outflow system may be the best option for patients with mild-to-moderate open-angle glaucoma.
Conclusion: The implantation of trabecular iStents resulted in a considerable reduction in IOP, particularly in mild and moderate POAG. Both MIGS versions have good efficacy and safety profiles, with only minor problems like microscopic hyphema and stent blockage.
Keywords: glaucoma, Minimally Invasive Glaucoma Surgery (MIGS), iStents, cypass
Full text article
References
Fingeret M, Dickerson JE. The role of minimally invasive glaucoma surgery devices in the management of glaucoma. Optom Vis Sci 2018; 95: 155–162.
Erb C, Jünemann AGM, Kimmich F. Micro-invasive glaucoma surgery ( MIGS ): a review of surgical procedures using stents. 2017; 1583–1600.
Vold S, Ahmed IIK, Craven ER, et al. Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts. Ophthalmology 2016; 123: 2103–2112.
Andrew NH, Akkach S, Casson RJ. A review of aqueous outflow resistance and its relevance to microinvasive glaucoma surgery. Surv Ophthalmol 2020; 65: 18–31.
Wang W, Zhang X. Meta-analysis of randomized controlled trials comparing EX-PRESS implantation with trabeculectomy for open-angle glaucoma. PLoS One; 9. Epub ahead of print 2014. DOI: 10.1371/journal.pone.0100578.
Kerr NM, Wang J, Barton K. Minimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma. Clin Exp Ophthalmol 2017; 45: 393–400.
Lavia C, Dallorto L, Maule M, et al. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis. 2017. Epub ahead of print 2017. DOI: 10.1371/journal.pone.0183142.
Ansari E. An Update on Implants for Minimally Invasive Glaucoma Surgery (MIGS). Ophthalmol Ther 2017; 6: 233–241.
Rosdahl JA, Gupta D. Prospective studies of minimally invasive glaucoma surgeries: Systematic review and quality assessment. Clin Ophthalmol 2020; 14: 231–243.
Ahmed IIK, Fea A, Au L, et al. A Prospective Randomized Trial Comparing Hydrus and iStent Microinvasive Glaucoma Surgery Implants for Standalone Treatment of Open-Angle Glaucoma: The COMPARE Study. Ophthalmology 2020; 127: 52–61.
Rulli E, Biagioli E, Riva I, et al. Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: A systematic review and meta-analysis. JAMA Ophthalmol 2013; 131: 1573–1582.
Hoeh H, Vold SD, Ahmed IK, et al. Initial clinical experience with the Cy pass micro-stent: Safety and surgical outcomes of a novel supraciliary microstent. J Glaucoma 2016; 25: 106–112.
Samuelson TW, Katz LJ, Wells JM, et al. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 2011; 118: 459–467.
Larsen CL, Samuelson TW. Managing coexistent cataract and glaucoma with iStent. Surv Ophthalmol 2017; 62: 706–711.
Jay Katz L, Erb C, Guillamet AC, et al. Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication. Clin Ophthalmol 2015; 9: 2313–2320.
Voskanyan L, García-Feijoó J, Belda JI, et al. Prospective, unmasked evaluation of the iStent® Inject system for open-angle glaucoma: Synergy trial. Adv Ther 2014; 31: 189–201.
Resende AF, Patel NS, Waisbourd M, et al. IStent® trabecular microbypass stent: An update. J Ophthalmol; 2016. Epub ahead of print 2016. DOI: 10.1155/2016/2731856.
Guedes RAP, Gravina DM, Lake JC, et al. One-Year Comparative Evaluation of iStent or iStent inject Implantation Combined with Cataract Surgery in a Single Center. Adv Ther 2019; 36: 2797–2810.
Clement CI, Howes F, Ioannidis AS, et al. One-year outcomes following implantation of second-generation trabecular micro-bypass stents in conjunction with cataract surgery for various types of glaucoma or ocular hypertension: Multicenter, multi-surgeon study. Clin Ophthalmol 2019; 13: 491–499.
Salimi A, Lapointe J, Harasymowycz P. One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities. Ophthalmol Ther 2019; 8: 563–575.
García-Feijoo J, Rau M, Grisanti S, et al. Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a multicenter study. Am J Ophthalmol 2015; 159: 1075-1081.e1.
Sheheitli H, Tirpack AR, Parrishii RK. Which Patients Would Most Likely to Benefit?: MIGS or MEGS , Which One Is It?? 2019; 436–440.
Shah M. Micro-invasive glaucoma surgery – an interventional glaucoma revolution. Eye Vis 2019; 6: 1–5.
Pfeiffer N, Garcia-Feijoo J, Martinez-De-La-Casa JM, et al. A Randomized Trial of a Schlemm’s Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma. Ophthalmology 2015; 122: 1283–1293.
Malvankar-Mehta MS, Iordanous Y, Chen YN, et al. iStent with Phacoemulsification versus Phacoemulsification Alone for Patients with Glaucoma and Cataract: A Meta-Analysis. PLoS One 2015; 10: e0131770–e0131770.
Klamann MKJ, Gonnermann J, Pahlitzsch M, et al. iStent inject in phakic open angle glaucoma. Graefe’s Arch Clin Exp Ophthalmol 2015; 253: 941–947.
Lindstrom R, Sarkisian SR, Lewis R, et al. Four-year outcomes of two second-generation trabecular micro-bypass stents in patients with open-angle glaucoma on one medication. Clin Ophthalmol 2020; 14: 71–80.
Authors
Copyright (c) 2023 Ridho Ranovian, Widya Artini Sumantri
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.